“…More than 100,000 breast reconstructions after mastectomy, and over 200,000 maxillofacial surgeries were performed in 2015 alone and it is predicted that there will be more than 12,000 new cases of soft-tissue sarcomas in the USA in 2016 [9,67]. The current treatment for many of these conditions is autologous lipotransfer, a procedure involving collecting fat tissue from a patient, minimally manipulating the resultant lipoaspirate and relocating it to the site of reconstruction [68][69][70][71]. Although used widely, reports show that there is extensive variability of longterm lipotransfer graft survival, due to unpredictable degrees of resorption and tissue volume loss that can range from 20 to 90% [32,72,73].…”